Correlation of E-cadherin expression and routine immunohistochemistry panel in breast invasive ductal carcinoma.
about
Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells.Withaferin A inhibits experimental epithelial-mesenchymal transition in MCF-10A cells and suppresses vimentin protein level in vivo in breast tumors.2'-hydroxyflavanone inhibits proliferation, tumor vascularization and promotes normal differentiation in VHL-mutant renal cell carcinomaChemopreventative potential of the cruciferous vegetable constituent phenethyl isothiocyanate in a mouse model of prostate cancer.Anti-metastatic and anti-tumor growth effects of Origanum majorana on highly metastatic human breast cancer cells: inhibition of NFκB signaling and reduction of nitric oxide production.Benzyl isothiocyanate inhibits epithelial-mesenchymal transition in cultured and xenografted human breast cancer cellsExpression of E-cadherin, N-cadherin and snail and their correlation with clinicopathological variants: an immunohistochemical study of 132 invasive ductal breast carcinomas in Egypt.Selection of a MCF-7 Breast Cancer Cell Subpopulation with High Sensitivity to IL-1β: Characterization of and Correlation between Morphological and Molecular Changes Leading to Increased Invasiveness.Arsenic sulfide inhibits cell migration and invasion of gastric cancer in vitro and in vivo.Molecular mechanisms controlling E-cadherin expression in breast cancer.Prevention of mammary carcinogenesis in MMTV-neu mice by cruciferous vegetable constituent benzyl isothiocyanate.Acute and chronic cadmium exposure promotes E-cadherin degradation in MCF7 breast cancer cells.Among triple-negative breast cancers, HER2(0) breast cancer shows a strong tendency to be basal-like compared with HER2(1+) breast cancer: preliminary results.Antitumor effects of matrine on cancer stem like cells isolated from the human liver cancer SMMC-7721 cell line.
P2860
Q33680909-76A86BA2-80E1-4625-AF6D-673C981C9426Q33690570-46B2CC8D-F548-4E9B-8F16-6E4D6FFBE2D6Q34734139-AC5356BA-CF71-4D95-96CD-0886649FE189Q34764877-1D8DB409-7FE7-430B-821C-383811DF699EQ34851241-02910328-6E7E-4966-BB19-74C7F62A7BF3Q35091219-30C087FB-AEDF-4CA3-AC97-023E2ED53D03Q35232419-2E63F0FC-4D3D-458A-8069-05625F0B8A08Q35979001-D027CF3B-838F-430D-BE50-08DCFD8730CDQ36165416-EB9FD21F-61B6-4AFD-941D-C20AA52496E6Q37238311-F473E395-B4D7-451E-9EC4-1D608B7AAE9BQ37480364-8E051B34-F56D-4717-83BA-64B5DC31B4A6Q38998346-04C85596-015E-42CE-A7B3-6244C297D7A5Q42486315-7A0120CB-537F-47BC-B38F-9971AC58AA3FQ50024794-155CE1C2-3C11-47F0-9A33-671A46098DD6
P2860
Correlation of E-cadherin expression and routine immunohistochemistry panel in breast invasive ductal carcinoma.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Correlation of E-cadherin expr ...... ast invasive ductal carcinoma.
@ast
Correlation of E-cadherin expr ...... ast invasive ductal carcinoma.
@en
type
label
Correlation of E-cadherin expr ...... ast invasive ductal carcinoma.
@ast
Correlation of E-cadherin expr ...... ast invasive ductal carcinoma.
@en
prefLabel
Correlation of E-cadherin expr ...... ast invasive ductal carcinoma.
@ast
Correlation of E-cadherin expr ...... ast invasive ductal carcinoma.
@en
P2093
P356
P1433
P1476
Correlation of E-cadherin expr ...... ast invasive ductal carcinoma.
@en
P2093
Alireza Mesbah
Amin Eftekhari
Azar Naimi
Hamidreza Ghasemibasir
Parvin Rajabi
P356
10.3233/CBM-2009-0551
P577
2009-01-01T00:00:00Z